Zurich, V8CIK 16745464 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
176 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Revolution Medicines Inc | 5.01M | $398.71M | 7.6% | −568.1K | Reduced |
| 2 | Argenx Se | 461.9K | $388.40M | 7.4% | −84.5K | Reduced |
| 3 | Ionis Pharmaceuticals Inc | 4.80M | $379.90M | 7.2% | −1.44M | Reduced |
| 4 | Vertex Pharmaceuticals Inc |
| 681.1K |
| $308.79M |
| 5.9% |
| +175.3K |
| Added |
| 5 | Neurocrine Biosciences Inc | 1.70M | $241.58M | 4.6% | −59.8K | Reduced |
| 6 | Avidity Biosciences Inc | 2.63M | $189.77M | 3.6% | +478.1K | Added |
| 7 | Intuitive Surgical Inc | 322.0K | $182.38M | 3.5% | −26.6K | Reduced |
| 8 | Scholar Rock Hldg Corp | 4.06M | $178.69M | 3.4% | +812.1K | Added |
| 9 | Alnylam Pharmaceuticals Inc | 445.9K | $177.31M | 3.4% | −621 | Reduced |
| 10 | Abbott Labs | 1.32M | $165.00M | 3.1% | −161.6K | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio